OliX Pharmaceuticals
We're hiring — explore open roles below and apply in a few clicks.
Location
Headquarters: Suwon, Ch'ungch'ong-namdo, South Korea, Asia
Region: Ch'ungch'ong-namdo
Country: KR
Continent: Asia
About
OliX Pharmaceuticals is a clinical-stage biotechnology company focused on RNA interference (RNAi)–based therapeutics. The company develops oligonucleotide platforms (asymmetric siRNA, cell-penetrating asiRNA, and GalNAc-asiRNA) to address locally administrable diseases like hypertrophic scars, hair loss, and AMD, as well as liver diseases (NASH/diabetes, HBV) through systemic liver-targeted therapies.
OliX Pharmaceuticals is a clinical-stage biotechnology company developing RNA interference-based therapeutics. It utilizes oligonucleotide platforms to treat locally administrable diseases such as hypertrophic scars and AMD, as well as liver diseases like NASH and HBV. The company targets patients with these specific conditions through its proprietary asiRNA technologies.
OliX Pharmaceuticals, Inc.
2010
for_profit
active
Industries
Primary Industry: Business Services
Funding & Financials
Public Company
82200000
1m-10m
ipo
226950
krx
Investors
Founders
Dong-ki Lee
Leadership
Technology Stack
Products
OLX101A: A treatment designed to inhibit the formation of hypertrophic and keloid scars by targeting the CTGF gene, reducing collagen production.
OLX301A: A treatment for both dry and wet age-related macular degeneration, targeting genes responsible for retinal pigment epithelial cell damage.
OLX301D: Targets CTGF to inhibit choroidal neovascularization and subretinal fibrosis, addressing a high unmet medical need in retinal diseases.
OLX702A: A treatment for metabolic dysfunction-associated steatohepatitis (MASH), targeting genes identified through GWAS to improve liver conditions.
OLX703A: A treatment for Hepatitis B, targeting common sequences in all HBV transcripts to reduce surface antigen levels in the blood.
OLX104C: A hair loss treatment that reduces androgen receptor expression to prevent male pattern baldness, applied locally to the scalp.
